RightFit Trial Directory

COPD clinical trials in Dallas, TX

13 recruiting copd studies with a site in Dallas, TX.

All trials in Dallas, TX · All COPD trials

RecruitingPhase 3NCT07190209

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Sponsor: Sanofi

Allen, TX · Beaumont, TX · Bellaire, TX · +72 more sites

RecruitingPhase not listedNCT04302272

STRIVE Post-Market Registry Study

Sponsor: Olympus Corporation of the Americas

Dallas, TX · Houston, TX · +13 more sites

RecruitingPhase 2NCT07610395

Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD

Sponsor: Altesa Biosciences, Inc.

Dallas, TX · Kingwood, TX · Lewisville, TX · +34 more sites

RecruitingPhase 3NCT06959095

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

Sponsor: GlaxoSmithKline

Corsicana, TX · Dallas, TX · Houston, TX · +39 more sites

RecruitingPhase 3NCT06961214

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Sponsor: GlaxoSmithKline

Austin, TX · Dallas, TX · El Paso, TX · +54 more sites

RecruitingPhase 3NCT06283966

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Sponsor: AstraZeneca

Abilene, TX · Amarillo, TX · Austin, TX · +232 more sites

RecruitingPhase 3NCT07190222

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Sponsor: Sanofi

Austin, TX · Dallas, TX · Denison, TX · +73 more sites

RecruitingNot applicableNCT06035120

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

Sponsor: Pulmonx Corporation

Dallas, TX · +19 more sites

RecruitingPhase 2NCT07082738

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Sponsor: AstraZeneca

Boerne, TX · Dallas, TX · Denison, TX · +83 more sites

RecruitingPhase 3NCT06883305

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Sponsor: AstraZeneca

Dallas, TX · Forney, TX · Fort Worth, TX · +70 more sites

RecruitingPhase 2 / Phase 3NCT07363694

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Sponsor: Pfizer

Boerne, TX · Carrollton, TX · Cypress, TX · +58 more sites

RecruitingPhase 3NCT07177339

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Sponsor: GlaxoSmithKline

Dallas, TX · DeSoto, TX · Greenville, TX · +39 more sites

RecruitingPhase not listedNCT05181826

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Sponsor: Helio Genomics

Dallas, TX · Richardson, TX · +5 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.